Quality of life of patients with type I diabetes mellitus

Quality of Life Research

Volumn 12, Issue 8, 2003, Pages 1089-1097

  Hart, H E ^a   Bilo, H J G ^b   Redekop, W K ^a   Stolk, R P ^c   Assink, J H ^d   Meyboom de Jong, B ^e  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Medisch Centrum Rijnmond Zuid   (Netherlands)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

EuroQol; Quality of life; RAND 36; Type I diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ANXIETY; ARTICLE; COMORBIDITY; DAILY LIFE ACTIVITY; DEPRESSION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; EUROPEAN QUALITY OF LIFE QUESTIONNAIRE; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PAIN ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RAND 36 HEALTH SURVEY; SELF CARE; VISUAL ANALOG SCALE;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE;

EID: 0242574506     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026197119569     Document Type: Article

References (41)

1. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428-1436.
2. DCCT: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.
3. DCCT: Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabet Care 1996; 19: 195-203.
4. Eiser C, Tooke JE. Quality-of-life evaluation in diabetes. Pharmacoeconomics 1993; 4: 85-91.
5. Coons SJ, Rao S, Keininger DL, Hays RD. A Comparative Review of Quality-of-Life Instruments. Pharmacoeconomics 2000; 17: 13-35.
6. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Int Med 1993; 118: 622-629.
7. Hutchinson AB, Konig-Zahn N, C. Cross cultural health outcome assessment; a user's guide. European Research Group on Health Outcomes. Groningen. The Netherlands, 1996.
8. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27: S217-S232.
9. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996; 334: 835-840.
10. Bradley C. Measuring quality of life in diabetes. Diabet Ann 1996; 10: 207-224.
11. Garrat AMSL, Futzpatrick R. Patient-assessed health outcome for measures for diabetes: A structured review. Diabet Med 2002; 19: 1-11.
12. Luscombe FA. Health-related quality of measurement in type 2 diabetes. Value health 2000; 3: 15-28.
13. Rubin RR, Peyrot M. Quality of life and diabetes. Diabet Metab Res Rev 1999; 15: 205-218.
14. Hays R, Sherbourne C, Mazel R. The RAND 36-item Health Survey 1.0. Health Econ 1993; 2: 217-227.
15. Zee vdKI, Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36. Een handleiding. Noordelijk Centrum voor gezondheidsvraagstukken. Rijksuniversiteit Groningen 1993; 1-28.
16. Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study. Med Care 1995; 33: AS264-AS279.
17. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 1055-68.
18. Zee vdKI, Sanderman R, Heyink J, Haes dH. The psychometric qualities of the RAND 36-item Health Survey 1.0: A multidimensional measure of general health status. Int J Behav Med 1996; 3: 104-122.
19. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-1108.
20. Essink-Bot ML, Stouthard ME, Bonsel GJ. Generalizability of valuations on health states collected with the EuroQol-questionnaire. Health Econ 1993; 2: 237-246.
21. Dutch Advisory on Health Research: Advice on chronic diseases: Priorities for research. Gravenhage, The Netherlands, 1991.
22. Jong dPTVM. Screening op diabetische retinopathie. Nederlands Tijdschrift voor Geneeskunde 1993; 137: 1701-1705.
23. Holewski JJ, Stess RM, Graf PM, Grunfeld C. Aesthesiometry: Quantification of cutaneous pressure sensation in diabetic peripheral neuropathy. J Rehabil Res Dev 1988; 25: 1-10.
24. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus (see comments). N Engl J Med 1993; 329: 304-309.
25. CBO NDF: Diabetische retinopathie, diabetische nefropathie. diabetische voet, harten vaatziekten bij diabetes mellitus, 1998.
26. EURODIAB: Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study. Diabetologia 1994; 37: 278-285.
27. Kind PH, G Macran S. UK Population Norms for EQ-5D. Centre for Health Economics, University of York, UK, 1999.
28. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: Results from a United Kingdom national questionnaire survey (see comments). Br Med J 1998; 316: 736-741.
29. Wikblad K, Leksell J, Wibell L. Health-related quality of life in relation to metabolic control and late complications in patients with insulin dependent diabetes mellitus. Qual Life Res 1996; 5: 123-130.
30. Wandell PE, Brorsson B, Aberg H. Quality of life among diabetic patients in Swedish primary health care and in the general population: Comparison between 1992 and 1995. Qual Life Res 1998; 7: 751-760.
31. Hahl J, Hämäläinen H, Sintoren H, Simell H, Arinen S, Simell O. Health related quality of life in type I diabetes without or with symptoms of long-term complications. Qual Life Res 2002; 11: 427-436.
32. Duijn NPG, Schuling K, Weert J, van H. Meyboom-de Jong B. The sensitivity to change of the COOP charts. Huisarts Wet 1995; 38: 139-143.
33. Ware JE, Kosinki M. Interpreting SF-36 summary health measures: A response. Qual Life Res 2001; 10: 405-413.
34. Aalto AM, Uutela A, Aro AR. Health related quality of life among insulin-dependent diabetics: Disease-related and psychosocial correlates. Patient Educ Couns 1997; 30: 215-225.
35. Bott U, Muhlhauser I, Overmann H, Berger M. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabet Care 1998; 21: 757-769.
36. Jacobson AM. de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabet Care 1994; 17: 267-274.
37. Hanestad BR. Self-reported quality of life and the effect of different clinical and demographic characteristics in people with type 1 diabetes. Diabet Res Clin Pract 1993; 19: 139-149.
38. Wu SY, Sainfort F, Tomar RH, et al. Development and application of a model to estimate the impact of type 1 diabetes on health-related quality of life. Diabet Care 1998; 21: 725-731.
39. UK Prospective Diabetes Study Group: Quality of life in Type 2 Diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabet Care 1999; 22: 1125-1136.
40. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GEH, Niessen LW. Health related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabet Care 2002; 25: 458-463.
41. Reviriego J, Millan MD, Millan M. Evaluation of the diabetes quality-of-life questionnaire in a Spanish population. An experience of translation and reliability. Pharmacoeconomics 1996; 10: 614-622.